OKLAHOMA CITY, June 21, 2007 (PRIME NEWSWIRE) -- AMS Health Sciences, Inc. (AMEX:AMM) today announced the election at its 2006 annual meeting of Ronald L. Smith (60) to the company's board of directors, succeeding Tom Buxton who did not stand for re-election.
"The addition of Ron Smith to our board further enhances the collective experience of the board at a momentous juncture in the company's evolution. Our recently launched Saba products, including the Saba Borojo weight loss formula, continue to gain market traction, and we anticipate numerous other potential opportunities to capitalize on these and other exciting products. Ron's extensive direct sales and multi-level marketing experience will be invaluable as the company executes its strategic growth plans, and we look forward to benefiting from his expertise," said Jerry Grizzle, Ph.D., president and chief executive officer of AMS Health Sciences.
Ronald L. Smith's career includes serving in a variety of positions with Mary Kay, Inc. for more than 20 years, including vice president of international operations, chief financial officer and treasurer, senior vice president of global business development and senior vice president of international administration. His tenure with Mary Kay included responsibility for opening numerous foreign operations in Asia, Europe and Latin America. He currently serves as a business consultant, with a focus on international direct sales, foreign operational issues, independent sales force compensation, market evaluations and related matters.
A U.S. Navy Vietnam veteran, Smith is a licensed certified public accountant and earned a bachelor's degree in business and public administration from the University of Texas, Dallas.
Separately, the company announced that Jerry Grizzle, Ph.D. and James L. Lee, Ph.D. were re-elected to three-year terms at the company's annual meeting of shareholders on June 18, 2007.
About AMS Health Sciences
AMS Health Sciences, Inc. develops and distributes nutritional, weight loss, and personal care products -- including antioxidants, pomegranate-based supplements, a proprietary blend of adaptogenic herbs developed by the late Dr. Israel Brekhman, minerals, vitamins and other nutritional supplements. Its products are sold through a network marketing system utilizing independent distributors in the United States, Puerto Rico, and Canada. Founded in 1988, the company is based in Oklahoma City, Oklahoma.
Additional information is available at www.amsonline.com.
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that represent the Company's current expectations and beliefs, including, among other things, the potential benefits of a new board member and the company's ability to capitalize on its new Saba product line. The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements of views expressed herein. These risks and uncertainties include, but are not limited to: (a) material decreases in active associates, or the company's failure to execute its strategic initiatives; (b) regulatory risks associated with the company's nutritional supplements, which could adversely affect the company if regulatory scrutiny dampens enthusiasm or the ability of the company or its associates to effectively market its products; (c) any failure of current or planned initiatives or products, including, among others, the introduction of the Saba line of nutritional supplements to generate interest among associates and customers and generate sponsoring and selling activities on a sustained basis; (d) any inability of the company to obtain necessary product registrations for its nutritional and personal care products in a timely manner; (e) adverse publicity related to the company's business, products or industry; and (f) continued competitive pressures in the company's markets. The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission, including the company's Annual Report on Form 10-KSB. The forward-looking statements set forth the company's beliefs as of the date of this release, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change.